Abstract
Overactive bladder (OAB) is a widespread condition that significantly impairs one's quality of life, yet it often goes undiagnosed and is treated inadequately due to various obstacles such as shame, poor communication, and poor patient compliance. There are several treatment options for OAB, including bladder and behavioural training, medications, and surgical therapies. Oral antimuscarinics are the primary choice for pharmacological treatment of OAB. There are a variety of drugs available to treat bladder storage and voiding issues, and soon, novel compounds with higher specificity for the lower urinary tract receptors will be available. This will help to optimize therapy, reducing side effects and improving adherence, particularly in patients with existing medical conditions and in women. This article provides an overview of the pharmacotherapy of OAB.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
